THE IN VITRO EFFECT OF LYSOSTAPHIN ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS.
D000900:Anti-Bacterial Agents; D001433:Bacteriolysis; D001434:Bacteriophage Typing; D004917:Erythromycin; D006801:Humans; D066298:In Vitro Techniques; D007612:Kanamycin; D008248:Lysostaphin; D010406:Penicillins; D010600:Pharmacology; D012106:Research; D012310:Ristocetin; D013203:Staphylococcal Infections; D013210:Staphylococcus; D013204:Staphylococcus Phages; D013211:Staphylococcus aureus; D013752:Tetracycline; D014640:Vancomycin
D000900:Anti-Bacterial Agents; D010406:Penicillins; D012310:Ristocetin; D007612:Kanamycin; D004917:Erythromycin; D014640:Vancomycin; D008248:Lysostaphin; D013752:Tetracycline
ANTIBIOTICS; BACTERIOLYSIS; BACTERIOPHAGE TYPING; ERYTHROMYCIN; EXPERIMENTAL LAB STUDY; KANAMYCIN; LYSOSTAPHIN; PENICILLIN; PHARMACOLOGY; RISTOCETIN; STAPHYLOCOCCAL PHAGES; STAPHYLOCOCCUS; TETRACYCLINE; VANCOMYCIN